Oregon AG sues insulin makers, PBMs for $900M over 'inflated' insulin prices

January 14, 2026 at 07:00 PM
Share & Print
NOT FOR REPRINT

© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected].

Related Stories

The employee-consumer experience is a golden opportunity for fintech and HR 1 in 3 employees say retirement is out of reach The future of work is colliding with the future of money Financial stress forces 38% of workers to miss work Financial stress is becoming a business problem for HR Form I-9 Compliance: Meeting Audit Requirements With Confidence